Peter Rizk

Peter Rizk, PharmD, CPGx, is a seasoned professional in the pharmaceutical industry with extensive experience in sales, marketing, and strategic account management. Currently serving as Sr. Director of Strategic Accounts at Alnylam Pharmaceuticals since April 2022, Peter has previously held significant roles at ACADIA Pharmaceuticals Inc. as Sr. Health System Manager and at Allergan as Regional Hospital Accounts Manager for Anti-Infectives. Peter's background also includes a national leadership position at HighRHealth LLC, focusing on sales and marketing consulting for biotechnology and specialty products. Prior roles at Eli Lilly & Company encompass various leadership positions, including Sr. Regional Director in the autoimmune sector and Sr. District Manager for musculoskeletal products, as well as involvement in global new product development and training. Peter holds a Doctor of Pharmacy degree from The University of Kansas, achieved between 1987 and 1992.